A new lymphoid-primed progenitor marked by Dach1 downregulation identified with single cell multi-omics.

Saved in:
Bibliographic Details
Title: A new lymphoid-primed progenitor marked by Dach1 downregulation identified with single cell multi-omics.
Authors: Amann-Zalcenstein D; Immunology Division, The Walter & Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.; Single Cell Open Research Endeavour (SCORE), The Walter & Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia., Tian L; Immunology Division, The Walter & Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.; Faculty of Medicine, Dentistry & Health Sciences, University of Melbourne, Parkville, Victoria, Australia.; Epigenetics and Development Division, The Walter & Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia., Schreuder J; Immunology Division, The Walter & Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia., Tomei S; Immunology Division, The Walter & Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.; Faculty of Medicine, Dentistry & Health Sciences, University of Melbourne, Parkville, Victoria, Australia., Lin DS; Immunology Division, The Walter & Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.; Faculty of Medicine, Dentistry & Health Sciences, University of Melbourne, Parkville, Victoria, Australia., Fairfax KA; Department of Medical Biology, The University of Melbourne, Parkville, Victoria, Australia.; Blood Cells and Blood Cancer Division, The Walter & Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.; Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia., Bolden JE; Department of Medical Biology, The University of Melbourne, Parkville, Victoria, Australia.; Blood Cells and Blood Cancer Division, The Walter & Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia., McKenzie MD; Department of Medical Biology, The University of Melbourne, Parkville, Victoria, Australia.; Inflammation Division, The Walter & Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia., Jarratt A; Department of Medical Biology, The University of Melbourne, Parkville, Victoria, Australia.; Blood Cells and Blood Cancer Division, The Walter & Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia., Hilton A; Department of Medical Biology, The University of Melbourne, Parkville, Victoria, Australia.; Blood Cells and Blood Cancer Division, The Walter & Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia., Jackson JT; Immunology Division, The Walter & Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.; Department of Medical Biology, The University of Melbourne, Parkville, Victoria, Australia., Di Rago L; Blood Cells and Blood Cancer Division, The Walter & Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia., McCormack MP; Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia., de Graaf CA; Department of Medical Biology, The University of Melbourne, Parkville, Victoria, Australia.; Blood Cells and Blood Cancer Division, The Walter & Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia., Stonehouse O; Faculty of Medicine, Dentistry & Health Sciences, University of Melbourne, Parkville, Victoria, Australia.; Epigenetics and Development Division, The Walter & Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia., Taoudi S; Epigenetics and Development Division, The Walter & Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.; Department of Medical Biology, The University of Melbourne, Parkville, Victoria, Australia., Alexander WS; Department of Medical Biology, The University of Melbourne, Parkville, Victoria, Australia.; Blood Cells and Blood Cancer Division, The Walter & Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia., Nutt SL; Immunology Division, The Walter & Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.; Department of Medical Biology, The University of Melbourne, Parkville, Victoria, Australia., Ritchie ME; Epigenetics and Development Division, The Walter & Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.; Department of Medical Biology, The University of Melbourne, Parkville, Victoria, Australia., Ng AP; Department of Medical Biology, The University of Melbourne, Parkville, Victoria, Australia.; Blood Cells and Blood Cancer Division, The Walter & Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.; Clinical Haematology, Peter MacCallum Cancer Centre & The Royal Melbourne Hospital, Parkville, Victoria, Australia., Naik SH; Immunology Division, The Walter & Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. naik.s@wehi.edu.au.; Single Cell Open Research Endeavour (SCORE), The Walter & Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. naik.s@wehi.edu.au.; Department of Medical Biology, The University of Melbourne, Parkville, Victoria, Australia. naik.s@wehi.edu.au.
Source: Nature immunology [Nat Immunol] 2020 Dec; Vol. 21 (12), pp. 1574-1584. Date of Electronic Publication: 2020 Oct 19.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature America Inc Country of Publication: United States NLM ID: 100941354 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1529-2916 (Electronic) Linking ISSN: 15292908 NLM ISO Abbreviation: Nat Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first